Pushkal Garg - EVP Chief R&D at Alnylam Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP Chief R&D
Stock Symbol
ALNY on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Pushkal Garg - trading volume in the past year for Alnylam Pharmaceuticals, Inc.

Holdings reported by Pushkal Garg for Alnylam Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 20.2K $9.19M $454.37 Oct 3, 2025 Direct
Restricted Stock Units 1.91K $466K $244.11 Feb 27, 2025 Direct Common Stock
Common Stock 431 $202K $469.31 Oct 1, 2025 by Managed Account
Common Stock 250 $117K $469.31 Oct 1, 2025 by Trust
Performance Stock Option 2015 (right to buy) 0 Jan 27, 2025 Direct Common Stock
Stock Option (right to buy) 0 Mar 24, 2025 Direct Common Stock

Transactions reported by Pushkal Garg for Alnylam Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.